Description
RufloxacinisafluoroquinoloneantibioticthatexhibitsantibacterialactivityagainstbothgramnegativeandgrampositivebacteriasuchasEscherichiaandHelicobacter.RufloxacininhibitstopoisomeraseIVandDNAgyrase.UnderUVexposure,rufloxacininducestypeIIguanineoxidation,increasingDNAbaseoxidationanddisplayingmutagenic/carcinogenicpotential.
References
GuLY,LinWW,LuH,etal.QuadrupletherapywithmedicationscontainingeitherrufloxacinorfurazolidoneasarescueregimeninthetreatmentofHelicobacterpylori-infecteddyspepsiapatients:arandomizedpilotstudy.Helicobacter.2011Aug;16(4):284-8.PMID:21762267.
BelvedereA,BoscáF,CatalfoA,etal.TypeIIguanineoxidationphotoinducedbytheantibacterialfluoroquinoloneRufloxacininisolatedDNAandin2"-deoxyguanosine.ChemResToxicol.2002Sep;15(9):1142-9.PMID:12230407.
MontanariMP,PrennaM,MingoiaM,etal.Invitroantibacterialactivityoftrovafloxacinandfiveotherfluoroquinolones.Chemotherapy.1998Mar-Apr;44(2):85-93.PMID:9551237.